CASE DISCUSSION
Endoscopic Closure of CSF Rhinorrhoea
Presented India by Dr. Vijay RangachariViews
595
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Cerebrospinal fluid (CSF) rhinorrhea presents a significant clinical challenge due to its representation of a breach in the anterior skull base, resulting in a persistent communication between the sterile subarachnoid space and the colonized nasal cavity. This defect carries a substantial risk of...
Case Summary
- Cerebrospinal fluid rhinorrhea represents a breach of the anterior skull base, resulting in a persistent conduit between the sterile subarachnoid space and the colonized nasal cavity, carrying a significant risk of ascending meningitis. Successful endoscopic endonasal repair requires a meticulous approach centered on three critical requirements: a bony defect, a dural tear, and persistent pressure facilitating CSF egress. The most common anatomical sites for these leaks are the cribriform plate and lateral lamella, the ethmoid roof, the sphenoid sinus lateral recess, and the posterior table of the frontal sinus.
Speaker Profile
Dr. Vijay Rangachari
Senior Consultant and Clinical Lead, Department of ENT and Endoscopic Skull Base Surgery, Manipal Hospitals, Whitefield, BengaluruDr. Vijay Rangachari is a Senior Consultant and Clinical Lead in the Department of ENT and Endoscopic Skull Base Surgery at Manipal Hospitals, Whitefield, Bengaluru. He is an experienced ENT and skull base surgeon with expertise in advanced endoscopic procedures and minimally invasive skull base surgery. His clinical interests include endoscopic management of CSF rhinorrhoea, sinonasal disorders, and complex skull base conditions. He is actively involved in patient care, surgical training, and advancing techniques in endoscopic skull base surgery.
Disclosures
Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.